Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Statera Biopharma Shares Fall After Taking Stake In Holographic Medical Imaging

Published 18/10/2022, 14:27
© Reuters. Statera Biopharma Shares Fall After Taking Stake In Holographic Medical Imaging

  • Statera Biopharma Inc (NASDAQ: STAB) signed a binding Memorandum of Understanding with Holobeam Technologies Inc.
  • Holobeam offers holographic medical imaging and therapeutic technologies for early cancer detection, treatment, and other diseases using Holographic Energy Teleportation (HET) technology.
  • Under the terms of the MOU, Statera will acquire a 25% interest in Holobeam for access to their technology and assist in targeting Statera drugs specifically to the site of cancer in concentrations that would not be possible under normal dosing.
  • The MOU provides an exclusivity period of sixty (60) days for negotiating and finalizing a definitive agreement.
  • Michael Handley, President & Chief Executive Officer of Statera, said, "Holobeam's technology also has the potential to precisely deliver focused energy to the tumor cells, thus making them more susceptible to therapeutic intervention."
  • In April, Statera Biopharma entered into a non-binding term sheet with Immune Therapeutics Inc (OTC: IMUN) to sell its naltrexone and met-enkephalin rights.
  • Under the anticipated terms, Statera will receive an initial $2 million upfront payment and 5% of the issued and outstanding stock of Immune Therapeutics.
  • Price Action: STAB shares are down 13.50% at $0.19 during the premarket session on the last check Tuesday.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.